Option chain shows key data for Kraig Biocraft's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kraig Biocraft.

Kraig Biocraft (OTC:KBLB) Stock, Option Chain

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra.

Penny Stocks

Short Ideas

Trading Ideas

KBLB

On Monday, shares of Kraig Biocraft Lab (OTC: KBLB) experienced volatile short activity. After the activity, the stock price went up +11.11% to $0.03.

The overall sentiment for KBLB has been Bearish.

Short Volatility Alert: Kraig Biocraft Lab

On Monday, shares of Kraig Biocraft Lab (OTC: KBLB) experienced volatile short activity. After the activity, the stock price went up +6.67% to $0.032.

The overall sentiment for KBLB has been Bearish.

On Friday, shares of Kraig Biocraft Laboratories, Inc. (OTC: KBLB) experienced volatile short activity. After the activity, the stock price went down 0% to $0.07.

The overall sentiment for KBLB has been Bearish.

Short Volatility Alert: Kraig Biocraft Laboratories, Inc.

KRAIG BIOCRAFT LABS INC by Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories Inc

Press Releases

General

Kraig Biocraft Laboratories Secures Four Registered Trademarks for SpydaSilk® Brand, to Advance Commercialization Strategy for Recombinant Spider Silk

News

Management

Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development

Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway

Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia

Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production

Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025

24/7 Market News - Kraig Biocraft Advances Toward First-Ever Spider Silk Deliveries to Luxury and Performance Giants

Health Care

Kraig Biocraft Laboratories Announces Senior Management Trip to Southeast Asia to Oversee Expansion of Spider Silk Production

Kraig Biocraft

Comments

Kraig Biocraft

Kraig Biocraft (KBLB) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell